Publikation: Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
When cells are stimulated with the cytokines IFN-γ or TNF-α, the synthesis of three proteasome subunits LMP2 (β1i), LMP7 (β5i), and MECL-1 (β2i) is induced. These subunits replace the three subunits delta (β1), MB1 (β5), and Z (β2), which bear the catalytically active sites of the proteasome, during proteasome neosynthesis. The cytokine-induced exchanges of three active site subunits of a complex protease is unprecedented in biology and one may expect a strong functional driving force for this system to evolve. These cytokine-induced replacements of proteasome subunits are believed to favour the production of peptide ligands of major histocompatibility complex (MHC) class I molecules for the stimulation of cytotoxic T cells. Although the peptide production by constitutive proteasomes is able to maintain peptide-dependent MHC class I cell surface expression in the absence of LMP2 and LMP7, these subunits were recently shown to be pivotal for the generation or destruction of several unique epitopes. In this review we discuss the recent data on LMP2/LMP7/MECL-1-dependent epitope generation and the functions of each of these subunit exchanges. We propose that these subunit exchanges have evolved not only to optimize class I peptide loading but also to generate LMP2/LMP7/MECL-1-dependent epitopes in inflammatory sites which are not proteolytically generated in uninflamed tissues. This difference in epitope generation may serve to better stimulate T cells in the sites of an ongoing immune response and to avoid autoimmunity in uninflamed tissues.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
GRÖTTRUP, Marcus, Selina KHAN, Katrin SCHWARZ, Gunter SCHMIDTKE, 2001. Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?. In: Biochimie. 2001, 83(3-4), pp. 367-372. ISSN 0300-9084. Available under: doi: 10.1016/S0300-9084(01)01251-2BibTex
@article{Grottrup2001Inter-22146, year={2001}, doi={10.1016/S0300-9084(01)01251-2}, title={Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?}, number={3-4}, volume={83}, issn={0300-9084}, journal={Biochimie}, pages={367--372}, author={Gröttrup, Marcus and Khan, Selina and Schwarz, Katrin and Schmidtke, Gunter} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/22146"> <dc:contributor>Schmidtke, Gunter</dc:contributor> <dc:rights>terms-of-use</dc:rights> <dcterms:title>Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?</dcterms:title> <dcterms:issued>2001</dcterms:issued> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/22146/2/Groettrup_221466.pdf"/> <dc:contributor>Schwarz, Katrin</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-03-18T10:06:55Z</dc:date> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/22146/2/Groettrup_221466.pdf"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/22146"/> <dc:contributor>Khan, Selina</dc:contributor> <dcterms:bibliographicCitation>Biochimie ; 83 (2001), 3-4. - S. 367-372</dcterms:bibliographicCitation> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-03-18T10:06:55Z</dcterms:available> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Gröttrup, Marcus</dc:contributor> <dc:creator>Gröttrup, Marcus</dc:creator> <dc:creator>Schwarz, Katrin</dc:creator> <dc:language>eng</dc:language> <dc:creator>Khan, Selina</dc:creator> <dcterms:abstract xml:lang="eng">When cells are stimulated with the cytokines IFN-γ or TNF-α, the synthesis of three proteasome subunits LMP2 (β1i), LMP7 (β5i), and MECL-1 (β2i) is induced. These subunits replace the three subunits delta (β1), MB1 (β5), and Z (β2), which bear the catalytically active sites of the proteasome, during proteasome neosynthesis. The cytokine-induced exchanges of three active site subunits of a complex protease is unprecedented in biology and one may expect a strong functional driving force for this system to evolve. These cytokine-induced replacements of proteasome subunits are believed to favour the production of peptide ligands of major histocompatibility complex (MHC) class I molecules for the stimulation of cytotoxic T cells. Although the peptide production by constitutive proteasomes is able to maintain peptide-dependent MHC class I cell surface expression in the absence of LMP2 and LMP7, these subunits were recently shown to be pivotal for the generation or destruction of several unique epitopes. In this review we discuss the recent data on LMP2/LMP7/MECL-1-dependent epitope generation and the functions of each of these subunit exchanges. We propose that these subunit exchanges have evolved not only to optimize class I peptide loading but also to generate LMP2/LMP7/MECL-1-dependent epitopes in inflammatory sites which are not proteolytically generated in uninflamed tissues. This difference in epitope generation may serve to better stimulate T cells in the sites of an ongoing immune response and to avoid autoimmunity in uninflamed tissues.</dcterms:abstract> <dc:creator>Schmidtke, Gunter</dc:creator> </rdf:Description> </rdf:RDF>